Natural catechin containing α-Lactalbumin based electrospun nanofibers for arthritis treatment and bone repair

IF 4.5 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Zhelong Zhang , Beini Cen , Junjie Xia , Hai Huang , Yichen Meng
{"title":"Natural catechin containing α-Lactalbumin based electrospun nanofibers for arthritis treatment and bone repair","authors":"Zhelong Zhang ,&nbsp;Beini Cen ,&nbsp;Junjie Xia ,&nbsp;Hai Huang ,&nbsp;Yichen Meng","doi":"10.1016/j.jddst.2025.107060","DOIUrl":null,"url":null,"abstract":"<div><div>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and bone erosion that pose significant challenges in orthopedics, necessitating innovative therapeutic approaches. Current treatments often have limited efficacy and significant side effects. Here, we report the development of α-lactalbumin-based curcumin-reinforced injectable electrospun nanofibers containing epigallocatechin gallate (EGCG) (EC/αL-NFs) for RA treatment and bone repair. The nanofibers exhibited excellent biocompatibility, biodegradability, and mechanical properties. Curcumin and EGCG incorporation significantly enhanced anti-inflammatory and antioxidant activities. <em>In vitro</em> and <em>in vivo</em> studies demonstrated the nanofibers' potential for RA treatment, reducing inflammation and promoting bone repair. The X-ray evaluations and immunohistochemical analysis revealed excellent treatment efficiency of the EC/αL-NFs for arthritis and bone chondrogenesis. The EC/αL-NFs also promoted osteogenic differentiation and bone matrix deposition. This study provides a promising approach for the development of injectable nanofibers for arthritis treatment and bone tissue engineering applications.</div></div>","PeriodicalId":15600,"journal":{"name":"Journal of Drug Delivery Science and Technology","volume":"110 ","pages":"Article 107060"},"PeriodicalIF":4.5000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Delivery Science and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1773224725004630","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and bone erosion that pose significant challenges in orthopedics, necessitating innovative therapeutic approaches. Current treatments often have limited efficacy and significant side effects. Here, we report the development of α-lactalbumin-based curcumin-reinforced injectable electrospun nanofibers containing epigallocatechin gallate (EGCG) (EC/αL-NFs) for RA treatment and bone repair. The nanofibers exhibited excellent biocompatibility, biodegradability, and mechanical properties. Curcumin and EGCG incorporation significantly enhanced anti-inflammatory and antioxidant activities. In vitro and in vivo studies demonstrated the nanofibers' potential for RA treatment, reducing inflammation and promoting bone repair. The X-ray evaluations and immunohistochemical analysis revealed excellent treatment efficiency of the EC/αL-NFs for arthritis and bone chondrogenesis. The EC/αL-NFs also promoted osteogenic differentiation and bone matrix deposition. This study provides a promising approach for the development of injectable nanofibers for arthritis treatment and bone tissue engineering applications.
含α-乳清蛋白的天然儿茶素静电纺丝纳米纤维用于关节炎治疗和骨修复
类风湿性关节炎(RA)是一种以关节炎症和骨质侵蚀为特征的慢性自身免疫性疾病,对骨科构成了重大挑战,需要创新的治疗方法。目前的治疗方法往往疗效有限,副作用明显。在这里,我们报道了基于α-乳蛋白的姜黄素增强的含有表没食子儿茶素没食子酸酯(EGCG) (EC/αL-NFs)的可注射静电纺纳米纤维的发展,用于RA治疗和骨修复。纳米纤维具有良好的生物相容性、生物降解性和力学性能。姜黄素和EGCG的掺入显著增强了抗炎和抗氧化活性。体外和体内研究表明,纳米纤维具有治疗类风湿性关节炎、减少炎症和促进骨修复的潜力。x线评价和免疫组化分析显示EC/αL-NFs对关节炎和骨软骨形成有良好的治疗效果。EC/αL-NFs还能促进成骨分化和骨基质沉积。该研究为可注射纳米纤维在关节炎治疗和骨组织工程中的应用提供了一条有前景的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.00
自引率
8.00%
发文量
879
审稿时长
94 days
期刊介绍: The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信